Specialty pharmaceutical
company Vansen Pharma announced it has acquired Ottawa- based Canada Health
Empire and its related company 6708595 Canada, Inc. (CHE, collectively), which
sell and market a portfolio of natural health products under brands like O2,
Zincola, Omega-3 Super Krill Oil, Bone Guard, and Ironex, among others.
In conjunction with the
acquisition of CHE, Vansen is acquiring the needed product registrations,
trademarks, starting material inventory, manufacturing expertise, import/export
permits, and customer information to continue selling and marketing the
products in various export markets. The acquisition’s financial terms were not
disclosed.
Strong loyalty has developed
for CHE’s products among sales and distribution partners, and with the
completion of the transaction, Vansen is acquiring a new revenue stream and a
platform for developing niche high-margin natural health brands in export
markets, which are anticipated to show triple-digit growth over the next few
years.
For more information, visit
the company’s website at www.vansenpharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com